Filing Flows › BioScience Health Innovations (BHIC) › Q2 2026 › vs Q1 2026
BioScience Health Innovations (BHIC) Q2 2026 vs Q1 2026 (quarter over quarter)
BioScience Health Innovations's revenue rose $285K (+38%) from $751K in Q1 2026 to $1.0M in Q2 2026.
BioScience Health Innovations, Q2 2026: revenue $1.0M (-41% year over year), operating margin -21.0%, net loss $186K, operating cash flow −$542K. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $1.0M | $751K | $285K | +38% |
| Income tax benefit | $32K | $0 | $32K | — |
| Net loss | $186K | $230K | −$44K | -19% |
| Costs & expenses | $1.3M | $981K | $273K | +28% |
| Operating costs | $1.3M | $981K | $273K | +28% |
| Cost of revenue | $377K | $265K | $112K | +42% |
| Research & development | $71K | $50K | $21K | +42% |
| Other operating costs | $3K | $40K | −$37K | -93% |
| Operating cash sources | $542K | $552K | −$10K | -2% |
| Cash used in operations | $542K | $552K | −$10K | -2% |
| Net loss absorbed | $186K | $230K | −$44K | -19% |
| Working capital & other | $356K | $322K | $34K | +11% |
Questions
How much did BioScience Health Innovations's revenue grow quarter over quarter in Q2 2026?
BioScience Health Innovations's revenue rose $285K (+38%) from $751K in Q1 2026 to $1.0M in Q2 2026.